New breast cancer treatment approved by FDA

Leading breast cancer specialist and medical oncologist, Robert Wesolowski, M.D. of the Ohio State University Comprehensive Cancer Center breaks down the latest breakthroughs in breast cancer treatment, including the newly FDA-approved targeted drug REVTORPYK (gedatolisib / Celcuity), how genetic markers like BRCA1 & BRCA2 guide care, and what the future of AI looks like in oncology.🔔 Subscribe to DoctorPodcasts: Don't forget to like this DoctorPodcasts Episode 171 video, leave a comment with your thoughts or questions, and share this episode with anyone navigating breast cancer treatment!⏱️ TIMESTAMPS & CHAPTERS:00:00 - Introduction & Meet Dr. Robert Wesolowski01:35 - Breast Cancer Statistics & Trends in Younger Populations04:03 - The 3 Main Subtypes: HR+, HER2+, & Triple-Negative06:50 - How Survival Rates & Outlook Have Transformed07:46 - BRCA1 vs. BRCA2 Genes: What Are the Risks?09:43 - Who Should Get Genetic Testing & Counseling?11:07 - Surgery vs. Radiation vs. Chemotherapy Decision Making14:09 - The Power of Neoadjuvant Chemotherapy & Targeted Drugs16:24 - REVTORPYK Breakthrough: Mechanism, Clinical Trial Data & FDA Approval19:17 - Administration Schedule & Managing Side Effects21:25 - How AI Is Revolutionizing Global Breast Cancer Care23:18 - Closing Remarks⚠️ Medical Disclaimer:This video podcast is for educational and informational purposes only and does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician regarding a medical condition.#BreastCancer #Oncology #REVTORPYK #CancerResearch #BRCA #WomensHealth #CancerTreatment #cancer #Cykiert #Celcuity #DoctorPodcasts

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(170)

New FDA-Approved BEQALZI Cancer Pill For Mantle Cell Lymphoma. Watch oncologist from MD Anderson Hospital in Houston Texas.

New FDA-Accelerated approval for BEQALZI pill to treat Mantle Cell Lymphoma cancers that are resistant to or recur with older treatments. Watch video podcast with expert, Michael Wang, M.D. , who expl...

27 Sep 19min

New FDA-Approved Gastro-Esophageal Cancer Breakthrough: How ZIIHERA Works; Oncologist Explains

What is ZIIHERA, and how is this newly FDA-approved targeted therapy transforming the treatment of advanced HER2-positive gastroesophageal cancer?In this episode 168 of DoctorPodcasts: Cykiert Files, ...

19 Sep 51min

Sanofi FDA-Approved Breakthrough Cancer Treatment Technology Is Transforming Multiple Myeloma Care

In this episode 167 of DoctorPodcasts: Cykiert Files, we explore the groundbreaking advancements in cancer therapy and how Sanofi’s new FDA-approved treatment Sarclisa Escena via a CirCLIQ On‑Body Inj...

11 Sep 29min

Colon Cancer Screening: At-Home Cologuard Plus & FDA-approved SimpleScreen CRC Blood Test Save Lives

Colon-rectal cancer is one of the leading causes of cancer-related deaths, yet it is highly treatable and preventable when detected early. Three world-renowned experts discuss the latest breakthroughs...

11 Sep 39min

Ozempic Face, Skin & Body; Breast Implants, Explants, Exchanges ; Plastic Surgery for Men: Top Plastic Surgeon Reveals the Truth About Plastic Surgery

In this episode 165 of the DoctorPodcasts show, host Dr. Robert Cykiert video interviews board-certified plastic surgeon Dr. Nirmal Nathan, founder of the Nathan Clinic in Miami, Florida to break down...

30 Aug 46min

High Triglycerides 500+ and Pancreatitis: Tryngolza with Dr. Brian Bergmark

High triglycerides over 500 can trigger life-threatening acute pancreatitis. Harvard and Brigham cardiologist Dr. Brian Bergmark explains severe hypertriglyceridemia, familial chylomicronemia syndrome...

29 Aug 28min

Musk’s SpaceX Delivers First Space-Bioprinted Organs to Earth. Exclusive with Anthony Atala, M.D.

First kidney and liver tissues ever bioprinted in space — and they just returned to Earth on a SpaceX Dragon capsule in June 2026.In this exclusive Episode 163 of the DoctorPodcasts Show, world-leadin...

19 Aug 29min